Luciano Marraffini
Gründer bei Eligo Bioscience SA
Profil
Luciano Marraffini is the founder of Intellia Therapeutics, Inc. (founded in 2014) and Eligo Bioscience SA (founded in 2014).
He holds a doctorate degree from The University of Chicago.
Aktive Positionen von Luciano Marraffini
| Unternehmen | Position | Beginn |
|---|---|---|
Eligo Bioscience SA
 Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Gründer | 01.05.2014 |
Ehemalige bekannte Positionen von Luciano Marraffini
| Unternehmen | Position | Ende |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Luciano Marraffini
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Health Services |
